I agree that this site is using cookies. You can find further informations here.
X
Festa, S
580  results:
Search for persons X
?
1

OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDER..:

Viola, A. ; Ventimiglia, M. ; Sparacino, A....
Digestive and Liver Disease.  56 (2024)  - p. S161-S163 , 2024
Link: https://doi.org/10.1016/..
 
?
2

T.05.3: NEW OR RECURRENT CANCER IN INFLAMMATORY BOWEL DISEA..:

Mancone, R. ; Neri, B. ; Fiorillo, M....
Digestive and Liver Disease.  56 (2024)  - p. S243-S244 , 2024
Link: https://doi.org/10.1016/..
 
?
3

P539 Assessment of VEdolizumab aNd Ustekinumab in Elderly p..:

Viola, A ; Ventimiglia, M ; Sparacino, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1059-i1061 , 2024
Link: https://doi.org/10.1093/..
 
?
4

Microbial community structure and metabolic profile of anth..:

Starevich, V. A. ; Madueño, L. ; Festa, S....
Environmental Monitoring and Assessment.  196 (2024)  6 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
5

P508 Pre-operative exposure to tofacitinib is as safe as bi..:

Dragoni, G ; Innocenti, T ; Amiot, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1005-i1006 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P908 Real-life effectiveness and safety of tofacitinib and ..:

Noviello, D ; Savarino, E ; Fries, W...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1660-i1661 , 2024
Link: https://doi.org/10.1093/..
 
?
7

A 1-year follow-up study on checkpoint inhibitor-induced co..:

Lenti, M.V. ; Ribaldone, D.G. ; Borrelli de Andreis, F....
ESMO Open.  9 (2024)  7 - p. 103632 , 2024
Link: https://doi.org/10.1016/..
 
?
8

P674 Ustekinumab is the preferred biological agent in IBD p..:

Verstockt ., B ; Vieujean, S ; Truyens, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i805-i806 , 2023
Link: https://doi.org/10.1093/..
 
?
9

Prevalence and predictors of suicidality among adults initi..:

Lent, Michelle R. ; Dugosh, Karen L. ; Hurstak, Emily...
Addiction Science & Clinical Practice.  18 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
10

T.04.4 IMPACT OF POSTOPERATIVE TREATMENT WITH IMMUNOMODULAT..:

Aratari, A. ; Scribano, M. ; Pugliese, D....
Digestive and Liver Disease.  54 (2022)  - p. S129-S130 , 2022
Link: https://doi.org/10.1016/..
 
?
11

P644 Impact of Postoperative Treatment with Immunomodulator..:

Aratari, A ; Scribano, M L ; Baccolini, V...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i559-i560 , 2022
Link: https://doi.org/10.1093/..
 
?
12

P268 IBD and Covid-19 in italy: comparisons between first a..:

Bezzio, C ; Costa, S ; Armuzzi, A...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i307-i308 , 2022
Link: https://doi.org/10.1093/..
 
?
13

T.06.7 INCIDENT COLORECTAL CANCER IN INFLAMMATORY BOWEL DIS..:

Neri, B. ; Scribano, M.L. ; Armuzzi, A....
Digestive and Liver Disease.  54 (2022)  - p. S140 , 2022
Link: https://doi.org/10.1016/..
 
?
14

DOP34 Long-term outcome of Acute Severe Ulcerative Colitis ..:

Festa, S ; Scribano, M L ; Aratari, A...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S072-S073 , 2021
Link: https://doi.org/10.1093/..
 
?
15

AF.52 LONG-TERM OUTCOME OF ACUTE SEVERE ULCERATIVE COLITIS ..:

Festa, S. ; Scribano, M.L. ; Aratari, A....
Digestive and Liver Disease.  53 (2021)  - p. S160 , 2021
Link: https://doi.org/10.1016/..
 
1-15